Ascendis Pharma (ASND) Tops Q2 EPS by EUR 37c, Beats on Revenue; Offers FY23 Revenue Guidance
Go back to Ascendis Pharma (ASND) Tops Q2 EPS by EUR 37c, Beats on Revenue; Offers FY23 Revenue Guidance| Asianada, Inc. (NASDAQ: ASND) | Delayed: 232.98 +4.98 (2.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $228.00 | 52 Week High | $21.79 | |||
| Open | $228.00 | 52 Week Low | $11.92 | |||
| Day High | $234.00 | P/E | N/A | |||
| Day Low | $222.82 | EPS | $-0.07 | |||
| Volume | 172,137 | |||||

